Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Hepatitis C Virus Infection- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Leiomyosarcoma - Pipeline Insight, 2023
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Leiomyosarcoma Understanding ... Read More
-
AL Amyloidosis- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage AL ... Read More
-
Sickle Cell Disease - Competitive landscape, 2023
... assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sickle Cell Disease: Understanding Sickle Cell Disease: Overview Sickle cell ... Read More
-
Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2029
... US$ 1,786.76 million in 2023 to US$ 8,890.05 million by 2029, at a Compound Annual Growth Rate (CAGR) of 30.66% during the forecast period. The global key companies of Artificial Intelligence in Drug Discovery include ... Read More
-
Amyotrophic Lateral Sclerosis- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Dermatomyositis - Pipeline Insight, 2023
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Dermatomyositis Understanding ... Read More
-
Axial spondyloarthritis (axSpA) - Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
... nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift ... Read More
-
Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
... projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023, at a CAGR of 12.4% during the forecast period of 2023 to 2028. . Continuous developments in sequencing technologies and a ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. No approved marketed drugs are currently available for the treatment of BDD. R&D activity within the BDD space is ... Read More
-
Global mRNA Vaccines & Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... market finds that the global mRNA Vaccines & Therapeutics market reached a value of USD 28037.12 million in 2022. It’s expected that the market will achieve USD 2883.86 million by 2028, exhibiting a CAGR of ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Review, 2023 provides an overview of Amyotrophic Lateral Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. Report includes an overview of trial numbers and ... Read More
-
Preclinical CRO Market Forecast till 2030
... therapies increases, pharmaceutical and biotech companies are allocating larger budgets for R&D to accelerate the drug development process. This includes outsourcing preclinical research activities to CROs, which offer specialized services and expertise in conducting preclinical ... Read More
-
BiSpecific mAbS Global Market Opportunities And Strategies To 2032
... need to assess the global bi-specific mAbS market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
-
Pancreatic Cancer Drugs Global Market Opportunities And Strategies To 2032
... information they need to assess the global Pancreatic cancer drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on ... Read More
-
Oncology Drugs Global Market Opportunities And Strategies To 2032
... need to assess the global oncology drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50 ... Read More
-
Proteomics Market Analysis And Forecast To 2032: By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others), Application (Diagnostic, Drug Discovery, and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, and Other), And Region
... Region The global Proteomics Market was valued at USD 22.4 Billion in 2022 and it is anticipated to grow up to USD 68.4 Billion by 2032, at a CAGR of 11.8% during the forecast period. ... Read More
-
Membranous Nephropathy
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Vietnam Stomach Cancer Treatment Market, By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery); By Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors); By Route of Administration (Oral, Injectable); By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others); By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Others); Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others); By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Others); Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Vietnam Stomach Cancer Treatment Market Size Set to Expand at Significant ... Read More
-
Pharmaceutical Contract Manufacturing Market by Service (Pharmaceutical (API, FDF - Tablet, Capsule, Injectable)), Biologic (API, FDF), Drug Development), End User (Big Pharma, Small & Medium-sized Pharma, Generic Pharma) - Global Forecast to 2028
... pharmaceutical contract development and manufacturing market size is projected to reach USD 258.3 billion by 2028 from USD 176.5 billion in 2023, at a CAGR of 7.9% during the forecast period. Factors such as increasing ... Read More
-
France Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the France market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More
-
Global Non-Hodgkin's Lymphoma Treatment Market Report and Forecast 2023-2031
... at a CAGR of 9.10% during the forecast period of 2023-2031 to reach a value of USD 18.18 billion by 2031. The market growth can be attributed to the increasing incidence of Non-Hodgkin's lymphoma and ... Read More
-
2023 Global: Bacterial Vaginosis Therapeutics - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
2023 Global: Diabetic Foot Ulcer Treatment - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
Research Assistance
